Navigation Links
ABAXIS Announces Appointment of Brenton Hanlon to Vice President of North American Medical Sales and Marketing
Date:8/10/2009

UNION CITY, Calif., Aug. 10 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis instruments for both the medical and veterinary markets, announced today the appointment of Brenton Hanlon to the position of vice president of North American medical sales and marketing, effective immediately. Mr. Hanlon, a member of the Abaxis Board of Directors since 1996, has resigned his position on the Board to assume this management/operational position within the Company.

Mr. Hanlon has been a medical diagnostic professional and corporate executive with more than 35 years of experience. He has a strong background in general management, marketing, sales, quality control and R&D experience with in-vitro diagnostics and medical companies.

From 2001 to August 2009, Mr. Hanlon served as president and chief executive officer of Hitachi Chemical Diagnostics, a manufacturer of in vitro allergy diagnostic products. Concurrently, from December 1996 until August 2009, Mr. Hanlon has served as president and chief operating officer of Tri-Continent Scientific, a subsidiary of Hitachi Chemical, specializing in liquid-handling products and instrument components for the medical diagnostics and biotechnology industries. From 1989 to December 1996, Mr. Hanlon was vice president and general manager of Tri-Continent Scientific. Mr. Hanlon serves on the board of directors of two privately-held companies.

Clint Severson, chairman and chief executive officer of Abaxis commented, "We are pleased to have an industry professional with the experience and skill set of Brenton Hanlon as our new vice president of North American Medical Sales and Marketing. Brenton has a long history of success in the industry and we believe he is uniquely qualified to lead Abaxis' sales and marketing initiatives into the future. His diagnostic industry expertise will be instrumental in the progression of Abaxis as a leading point of care technology provider. I look forward to working very closely with Brenton in the coming years."

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

Private Securities Litigation Reform Act of 1995

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Abaxis claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. Specific forward-looking statements contained in this press release include, but are not limited to, risks and uncertainties related to the market acceptance of the Company's products and the continuing development of its products, risks associated with manufacturing and distributing its products on a commercial scale, risks associated with entering the human diagnostic market on a larger scale, risks involved in carrying of inventory, risks from unexpected problems or delays in the Company's manufacturing facility, risks associated with the ability to attract and retain competent sales personnel, general market conditions, competition, risks and uncertainties related to its ability to raise capital in order to fund its operations and other risks detailed from time to time in Abaxis' periodic reports filed with the United States Securities and Exchange Commission. Forward-looking statements speak only as of the date the statement was made. Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.

    Contact:  Clint Severson             Lytham Partners, LLC
              Chief Executive Officer    Joe Dorame, Robert Blum and Joe Diaz
              Abaxis, Inc.               602-889-9700
              510-675-6500


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Abaxis Reports Record Financial Performance for the First Quarter of Fiscal 2010
2. Abaxis to Report First Quarter Fiscal 2010 Financial Results Thursday, July 30, 2009
3. Abaxis, Inc. to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
4. Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2009
5. Abaxis to Report Fourth Quarter Fiscal 2009 Financial Results Wednesday, April 29, 2009
6. ABAXIS Realigns North American Medical Sales and Marketing
7. Abaxis, Inc. to Attend Lazard Capital Markets Medical Technologies Conference
8. Abaxis, Inc. to Present at Sidoti & Companys Thirteenth Annual New York Emerging Growth Institutional Investor Forum
9. Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009
10. ABAXIS Announces Launch of Two New Products at the NAVC
11. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Donor Network West, the organ ... Nevada, announced a partnership with San Ramon Regional Medical Center. Under the collaboration, the ... as a way to accommodate a more certain time frame for donor families for ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mediaplanet today ... , The print component of “Revolutionizing Cancer Care” is distributed within the February ... and Seattle, with a circulation of approximately 250,000 copies and an estimated readership ...
(Date:2/12/2016)... ... ... US Sport Camps is pleased to announce the addition of junior golf ... the host site and directing the camps is PGA Professional and 2008 Iowa State ... recent years around Des Moines and are fortunate to have such a well-respected instructor ...
(Date:2/12/2016)... ... 2016 , ... The aging population and longer life spans ... With that, says Patrick Loughney, president of Longtree & Associates, LLC ... care environments. His company, which offers prep courses and workshops in long term ...
(Date:2/12/2016)... ... February 12, 2016 , ... With the exception of restorative dentistry, to date there has ... With the recent approval by the FDA, there is a now a new protocol in ... SDF is very simple and quick to apply. The application is as simple as ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016  Memorial Hermann Health System has ... Howard to bring a one-of-a-kind experience to pediatric ... cutting-edge technologies such as 360-degree video and Google Cardboard, ... then literally – giving the patients and their families ... was all caught on video . ...
(Date:2/12/2016)... 12, 2016 On Thursday, Feb. 11, 2016, ... St. David,s North Austin Medical Center successfully completed the ... Xi ® Surgical System with Trumpf Medical,s advanced ... Thiru Lakshman , M.D., colorectal surgeon at the Texas ... Integrated Table Motion technology, which seamlessly combines the da ...
(Date:2/12/2016)... 2016  Eli Lilly and Company (NYSE: LLY ) ... (pemetrexed disodium) vitamin regimen patent would not presently be infringed ... France , Italy and ... only with dextrose solution.  --> ... of Appeal held that Lilly,s patent would be indirectly infringed ...
Breaking Medicine Technology: